BRD4 was firstly described as a proliferative target in a cancer study of nuclear testis protein (NUT) midline carcinoma caused by the nuclear translocation of the BRD4-NUT oncogene product (Wang and You, 2015). The gene discussed is BRD4; the disease is cancer.